Top Markets
#1 CoW Protocol CoW Protocol +84.93%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.25%
#4 Walrus Walrus +36.32%
#5 Humanity Humanity +16.84%
#6 Velvet Velvet +16.00%
#7 Cysic Cysic +15.83%
#8 The Black Bull The Black Bull +14.62%
#9 Tutorial Tutorial +14.59%
#10 Plume Plume +14.14%
Coin of the day
CoW Protocol CoW Protocol
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Rankning i aktier #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Aktiekurs
$0.2488447
Senast synkroniserad: 2024-10-01
Marknadsvärde
$2.01M
Förändring (1 dag)
-1.88%
Förändring (1 år)
0.00%
Land
IN
Handel Ortin Laboratories Limited (ORTINLAB)

Kategori

Healthcare
Antal utestående aktier för Ortin Laboratories Limited (ORTINLAB)
Antal utestående aktier per June 2024: 8.13M
Enligt de senaste finansiella rapporterna och aktiekursen för Ortin Laboratories Limited är det aktuella antalet utestående aktier 8.13M. I slutet av March 2023 hade företaget 8.13M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Ortin Laboratories Limited (ORTINLAB) från 2008 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
2026 (TTM) 8.13M 0.01%
2024 8.13M -0.01%
2023 8.13M 0.00%
2022 8.13M -0.23%
2021 8.15M 0.24%
2020 8.13M 0.00%
2019 8.13M 0.00%
2018 8.13M 0.00%
2017 8.13M 0.00%
2016 8.13M -0.01%
2015 8.13M -0.04%
2014 8.14M -0.70%
2013 8.19M 0.23%
2012 8.17M 0.52%
2011 8.13M 361.54%
2010 1.76M 0.00%
2009 1.76M -0.01%
2008 1.76M 0.00%
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 2.40B 29,407.06%
IN